NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
-
-
FDA authorized first Mpox point-of-care test
On Feb. 10, 2023, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
-
Large-scale genetic analysis showed microRNAs in human pancreas associated with diabetes
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
-
Bivalent boosters provided better protection against severe COVID-19
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
-
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
-
New MRI method provided detailed view of the placenta during pregnancy
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
-
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
-
Biotechnology | HIV | NIH | Vaccine
Experimental HIV vaccine regimen safe but ineffective, study found
On Jan. 18, 2023, the National Institutes of Health (NIH) announced that an investigational HIV vaccine regimen tested…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
Hutchinson Cancer Center leads large-scale review of COVID-19 clinical trials that highlights multiple disparities
On Dec. 5, 2022, the Fred Hutchinson Cancer Center announced that according to a new meta-analysis women were…
-
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
NIH researchers unlocked pattern of gene activity for ADHD
On Nov. 16, 2022, researchers at the National Institutes of Health (NIH) announced they had successfully identified differences…
-
First ever clinical trial of laboratory grown red blood cells being transfused into another person
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
-
Biotechnology | COVID-19 | Diagnostics | Disease | NIH | Therapeutics
NIH-funded study showed blood pressure levels rose during pandemic
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
-
NIH awarded USC $11.7 million to develop implantable devices for the nervous system
On Oct. 26, 2022, the NIH announced it had awarded the University of Southern California (USC) $11.7 million…
-
NIH awarded University of Missouri $8 million grant to expand National Swine Resource and Research Center
On Oct. 25, 2022, the National Institutes of Health (NIH) announced that the University of Missouri had been…
-
Biotechnology | HIV | NIH
Early HIV diagnosis and treatment important for better long-term health outcomes
On Oct. 24, 2022, the National Institutes of Health announced that starting antiretroviral treatment (ART) early in the…
-
Biotechnology | HIV | NIH | Vaccine
Three-dose hepatitis B vaccine regimen protected people with HIV
On Oct. 20, 2022, the National Institutes of Health announced that a three-dose course of the hepatitis B…
-
Study confirmed link between COVID-19 vaccination and temporary increase in menstrual cycle length
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH established initiative to systematically investigate and establish function of every human gene
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
-
Salk Institute to lead $126 million effort to map the aging human brain
On Supt. 22, 2022, with a five-year, $126 million grant from the National Institutes of Health (NIH), a…
-
Diagnostics | FDA | NIH | Oncology
U.S. recorded steady decline in cancer death rates
On Sept. 21, 2022, the American Association for Cancer Research (AACR) released the 12th edition of its AACR…
-
NIH-funded team developed method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance
On Sept. 15, 2022, the National Institutes of Health (NIH) announced that a research team funded by the…
-
Biotechnology | Infectious Disease | NIH | U.S. Congress | USDA | Vaccine
The White House announced actions to combat Mpox outbreak
On Aug. 18, 2022, the White House announced that the U.S. Department of Health and Human Services (HHS)…
-
Biotechnology | FDA | Infectious Disease | NIH | Therapeutics | Vaccine
U.S. Department of Health and Human Services made more vaccine doses available to support Mpox response
On Aug. 15, 2022, the U.S. Department of Health and Human Services announced that was making up to…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | U.S. Congress | Vaccine
U.S. Department of Health and Human Services declared Mpox a public health emergency
On Aug. 4, 2022, the U.S. Department of Health and Human Services declared the ongoing spread of monkeypox…
-
Biotechnology | COVID-19 | NIH | Therapeutics | Vaccine
HHS announced 66 million doses of Moderna’s variant-specific COVID-19 vaccine booster for potential use in Fall and Winter 2022
On Jul. 29, 2022, the U.S. Department of Health and Human Services (HHS), in collaboration with the U.S….
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Vacations Redux
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
-
COVID-19 | Infectious Disease | NIH | Therapeutics | Vaccine
Vaccine-induced immune response to Omicron wanes substantially over time
On Jul. 19, 2022, the National Institutes of Health (NIH) announced that although COVID-19 booster vaccinations in adults…
-
U.S. Government secured 3.2 million doses of Novavax COVID-19 vaccine
On Jul. 11, 2022, Novavax announced an agreement with the U.S. Department of Health and Human Services (HHS),…
-
NIH launched clinical trial of mRNA Nipah virus vaccine
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
